Amsterdam Center for Computational Cardiology
Advancing discoveries with cutting-edge research in cardiovascular health
Our dedicated team of data scientists, epidemiologists, and clinicians collaborate to bring about innovative advancements in computational cardiology, utilizing state-of-the-art techniques and technologies.
Pioneering the future of cardiovascular health utilizing state-of-the-art techniques and technologies.
leveraging multi-modal clinical data spanning information from imaging, genomics, electronic healthcare records, and clinical trials.
leveraging multi-modal clinical data spanning information from imaging, genomics, electronic healthcare records, and clinical trials.
projectsInnovative projects shaping the future of cardiovascular health
We are participating in groundbreaking initiatives to advance cardiovascular health through cutting-edge technologies and data-driven solutions. The projects focus on precision medicine, early disease detection, and the integration of artificial intelligence to transform cardiovascular health care. By combining interdisciplinary expertise and innovative methodologies, we aim to set new standards in cardiovascular research and patient care.

AI4HF
Focuses on co-design, development, evaluation and exploitation of integrative and thrustworthy artificial intelligence solutions for personalized heart failure risk-assessment. The consortium is led by Amsterdam UMC.

CHECK@HOME
Introduces a national approach in the Netherlands for early detection of CV disease, kidney disease, and type 2 diabetes. Its goal is to reduce the morbidity and mortality of these conditions by 25% over the next decade

DataTools4Heart
Aims for the co-creation, development and demonstration of a comprehensive, federated, privacy-preserved cardiology data toolbox including standardized data ingestion and harmonization tools, multilingual natural language processing and federated machine learning and data synthesis methods.

Heart4Data
Aims to develop a sustainable infrastructure for cardiovascular registry-based research in the Netherlands. The infrastructure includes a framework/structure for the governance, and the ethical, legal, financial, technological and methodological factors.

HOVON 170 DLBCL
This is a national, multicenter, randomized controlled phase III trial designed to evaluate the efficacy and safety of dexrazoxane for the primary prevention of anthracycline-induced cardiac dysfunction in patients with non-Hodgkin lymphoma.

PROMPT-HF-AUMC
This is a nudging trial performed in the Amsterdam UMC designed to explore the effectiveness of subtle behavioral interventions, known as "nudges," in influencing people's or doctor’s decisions and actions without restricting their freedom of choice.